Article: 1998 Nobel Prize Laureate Joins Cytoclonal's Scientific Advisory Board.

Dr. John Pople, Chemistry Nobel Prize Winner, is Newest Addition

to Cytoclonal's Board

DALLAS, Oct. 14 /PRNewswire/ -- Cytoclonal Pharmaceutics Inc. (Nasdaq: CYPH, CYPHW, CYPHZ) today announced John Pople, Ph.D. has joined the Company's Scientific Advisory Board. A 1998 Nobel Prize Laureate in Chemistry, Dr. Pople was awarded the Nobel Prize for his pioneering development of computational methods in chemistry, based on the theory of quantum mechanics.

One of two scientists to receive a 1998 Nobel Prize in chemistry, Dr. Pople developed computational methods in the study of molecules, their properties, and how they interact in chemical ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!